A Hochhaus | oncology.medicinematters.com
Skip to main content
Menu
Latest news
Browse specialties
Chevron down icon
Chevron up icon
Breast cancer
Genitourinary cancers
Lung & thoracic cancers
In focus
Chevron down icon
Chevron up icon
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs
ctDNA and bladder cancer: Current understanding and beyond
ROS1 fusion-positive NSCLC
NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC
Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy
ALK fusion-positive NSCLC: International approaches to management
RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC
COVID-19 & cancer
Conferences
Chevron down icon
Chevron up icon
SABCS 2022
ESMO 2022
2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
Medicine Matters Oncology
Search
Search icon
EXTENDED SEARCH
Medicine Matters Oncology
A Hochhaus
Contact
address:
Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany
print
PRINT